With the fanfare of a holiday parade, drug companies last year unveiled two new Cox-2
inhibitor drugs - Celebrex and Vioxx - to treat arthritis, inflammation, premenstrual syndrome,
and potentially even cancer. All the hoopla paid off. Since then, doctors have written more than
seven million prescriptions for these "super aspirin" drugs, earning hundreds of million
dollars for their makers.
Cox-2 is short for cyclooxygenase-2, one of the key enzymes that helps the body produce inflammatory hormone-like compounds called prostaglandins and cytokines. Cox-2 is essential - without it, we wouldn't be able to fight infections or heal injuries. But when the body overproduces Cox-2, the result is chronic inflammation and pain.
The intensive marketing and advertising of Cox-2 inhibitors obscured why many people overproduce the enzyme. Too much Cox-2 appears to result from imbalances and deficiencies of certain nutrients. Rather than correct these underlying dietary problems, pharmaceutical Cox 2 inhibitors only mask the most visible symptoms. Relatively minor dietary changes, plus some vitamin and herbal supplements, correct the underlying problems.
Problems with Cox-2 Inhibitor Drugs
For years, people have used nonsteroidal antiinflammatory drugs (NSAIDS), such as ibuprofen, to treat the inflammation and pain associated with rheumatoid arthritis and osteoarthritis. NSAIDS ease inflammation by inhibiting the activity of both Cox-2 and Cox-1, the latter an enzyme that helps maintain homeostasis (biological equilibrium) protect the stomach lining. Because stomach ulcers occur in about 25 percent of NSAID users, pharmaceutical companies worked to develop NSAIDS that blocked only the activity of Cox-2. The idea was that a selective Cox-2 inhibitor would reduce inflammation but not irritate the stomach.
The motivation was profiting from a potentially huge market. An estimated 40 million Americans suffer from some form of arthritis. In a typical year, physicians write about 60 million prescriptions for NSAIDS - to say nothing of their over-the-counter sales. However, each year some half-million people develop complications from NSAIDS, with an estimated 80,000 people requiring hospitalization and 8,000 dying.
Though touted for their relative safety, Cox-2 inhibitors may be far more hazardous than originally believed. While gastrointestinal problems with Cox-2 inhibitors occur less frequently, they can be severe. Just four months after the FDA approved Celebrex, 10 deaths from the drug were reported. One study has even suggested that Cox-2 is important to the gut and healing ulcers, suggesting that pharmaceutical tampering with the enzyme may not be wise.
The Double-Edged Sword of Inflammation
Nutrients supply the most basic building blocks of the body's powerful inflammatory compounds. The "parent" nutrient is linoleic acid, found in many foods but especially concentrated in vegetable oils (e.g., corn, soy, and safflower oils). The body converts linoleic acid to the omega-6 family of fatty acids, including arachidonic acid. Cox-2 plays a critical role in converting arachidonic acid to the hormone-like prostaglandin E2 (PGE2) and to the cytokines interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNFa), all of which promote inflammation.
According to Robert F. Grimble, Ph.D., of the University of Southampton, England, once an infection or injury stimulates production of IL-1 and TNFa, these two proinflammatory compounds can further stimulate each other, as well as IL-6. In addition, IL-1 and TNFa trigger the production of free radicals, which encourage the production of more proinflammatory cytokines. The proinflammatory reaction essentially feeds on itself, setting the stage for chronic inflammation.
Ideally, the body balances these compounds with a group of antiinflammatory compounds that originate with alpha-linolenic acid, found in cold-water fish, leafy green vegetables, and flaxseed. The body converts alpha-linolenic acid to the omega-3 family of fatty acids, which include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Preformed EPA and DHA are also found in cold-water fish.
Much of the problem with inflammatory disorders actually stems from a lopsided imbalance in dietary intake of the omega-6 and omega-3 fatty acids - and the consequential cascade in proinflammatory activity. Artemis Simopolous, M.D., director of the Center for Genetics, Nutrition and Health in Washington, D.C., has shown that people historically consumed roughly equal amounts of the proinflammatory omega-6 fatty acids and the antiinflammatory omega-3 fatty acids.
However, over the past 30 years or so, Americans have replaced much of their dietary saturated fat (a bystander, so far as inflammation is concerned) with omega-6 fatty acids. Simopoulos estimates that people are now eating 20 times more omega-6s than omega-3s. From a biochemical standpoint, this sets the stage for powerful and chronic proinflammatory reactions.
Indeed, inflammation plays a role in many diseases, including arthritis, gingivitis and most of "-itis" diseases. Recent research has pointed to the role of inflammation in heart disease, stroke, and even Alzheimer's disease. In addition, Bruce N. Ames, Ph.D., of the University of California, Berkeley, has estimated that chronic inflammation and infection cause about one third of all cancers.
This relationship between diet, inflammation, and cancer was recently demonstrated by researchers at the American Health Foundation, Valhalla, New York. In animal experiments, they noted that corn oil (rich in omega-6) increased Cox-2 activity, whereas fish oil (rich in omega-3) blunted Cox-2 activity. The researchers also showed that the omega-6 fatty acids could promote the growth of colon cancer, whereas the omega-3 fatty acids prevented cancer.
In addition to a diet containing too many omega-6 fatty acids, a shortage of nutritional antioxidants, such as vitamin E, also contributes to chronic inflammation. The proinflammatory cytokines, IL-1 and TNFa, trigger the release of free radicals. A diet rich in antioxidants - found chiefly in vegetables and fruit - can help neutralize these free radicals. But relatively few people - 9 to 34 percent, according to different researchers - eat the recommended five daily servings of vegetables and fruit. Between an excess omega-6 fatty acids and a lack of omega-3 fatty acids, and inadequate intake of antioxidants, the body's proinflammatory reaction goes out of control, leading to chronic inflammation and pain.
Quenching the Fires of Inflammation
The simplest and most biochemically sound way of turning down the body's proinflammatory prostaglandins and cytokines is by restoring a balance between pro- and antiinflammatory foods. From a dietary standpoint, this means switching from vegetable oils to extra-virgin olive oil (high in antiinflammatory omega-9 fatty acids). It also means avoiding most processed (boxed, canned, or frozen) foods, because their makers frequently add omega-6 fatty acids. By eating simple unprocessed foods - such as baked chicken, a salad, and steamed vegetables - it becomes easier to consume a more balanced ratio of omega-6 and omega-3 fatty acids.
However, if you're like most people, you've been eating a diet high in omega-6 fatty acids and low in antioxidants for years. Simply restoring a balance is not enough to quickly offset accumulated damage, because the fatty acid composition of the body's cells reflects their dietary ratios. It's imperative to increase consumption of antiinflammatory fatty acids and antioxidants.
These are the supplements to emphasize:
REFERENCES
Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nature Medicine, 1999;5:1418-1423.
Grimble RF. Nutritional Modulation of Cytokine Biology. Nutrition, 1998;14:634-640.
Grimble RF. Modification of inflammatory aspects of immune function by nutrients. Nutrition Research, 1998;18:1297-1317.
Simopoulos AP. Overview of Evolutionary aspects of omega-3 fatty acids in the diet. In The Return of Omega-3 Fatty Acids into the Food Supply, World Review of Nutrition and Dietetics. Ed: Simopoulos AP. Basel: Karger, 1998:1-11.
Simopoulos AP. Overview of Evolutionary aspects of omega-3 fatty acids in the diet. In The Return of Omega-3 Fatty Acids into the Food Supply, World Review of Nutrition and Dietetics. Ed: Simopoulos AP. Basel: Karger, 1998:1-11.
Ross R. Atherosclerosis - An Inflammatory Disease. New England Journal of Medicine, 1999;340:115-126.
DeGraba TJ. The role of inflammation after acute stroke. Utility of pursuing anti-adhesion molecule therapy. Neurology, 1998;51(Suppl 3):S62-S68.
Anon. Inflammation tied to Alzheimer's risk. Reuters, July 16, 1998.
Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proceedings of the National Academy of Sciences, 1995;92:5258-5265.
Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Research, 1997;57:3465-3470.
Curtis CL, Hughes CE, Flannery CR, et al. n-4 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. Journal of Biological Chemistry, 2000,275:721 724.
Wu D, Meydani M, Leka LS, et al. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. American Journal of Clinical Nutrition, 1999;70:536-543.
Wu D, Mura C, Beharka AA, et al. Age-associated increase in PGE2 and COX activity in murine macrophages is reversed by vitamin E. American Journal of Physiology, 1999;275:(3 Pt 1):C661-668.
Edmonds SE, Winyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Annals of the Rheumatic Diseases, 1997;56:649-655.
Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation. Free Radical Biology & Medicine, 1998;25:1006-1012.
Skaper SD, Fabris M, Ferrari V, et al. Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radical Biology & Medicine, 1997;22:669-78.
Haqqi TM, Anthony DD, Gupta S, et al. Prevention of colleage-induced arthritis in mice by a polyphenolic fraction from green tea. Proceedings of the National Academy of Sciences, 1999;96:4524-4529.
Sakamoto W, Fujie K, Nishihira J, et al. Effect of vitamin E on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated rat macrophages. Biochim Biophys Acta, 1996;1304:139 144.
Liang YV, Huang YT, Tsai SN, et al. Suppression of inducible cyclooxygenase and inducible nitric oxide synthesis by apigenin and related flavonoids in mouse macrophages. Carcinogenesis, 1999;20:1945-1952.
Bork PM, Bacher S, Schmitz ML, "Hypericin as a non-antioxidant inhibitor of NF-kappa B," Planta Medica, 1999;65:297-300.
Zhao J, Sharma Y, Agarwal R. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion. Mol Carcinog, 1999;26:321-33.
Park K-K, Chun K-S, Lee J-M, et al. Inhibitory effects of [6]-gingerol, a major pungent principle of ginger, on phorbol ester-induced inflammation, epidermal ornithine decarboxylase activity and skin tumor promotion in ICR mice. Cancer Letters, 1998;129:139-144.
Vimala S, Norhanom AW, Yadov M. Anti-tumour promoter activity of Malaysian ginger rhizobia used in traditional medicine. British Journal of Cancer, 1999;80:110-116.
Ringborn T, Segura L, Noreen Y, et al. Ursolic acid from Plantago major, a selective inhibitor of cyclooxygenase-2 catalyzed by prostaglandin biosynthesis. Journal of Natural Products, 1998;61:1212-1215.
Zhang F, Altorki NK, Mestre JR, et al. Curcumin inhibits cyclooxygenase-1 transcription in bil acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis, 1999;20:445-451.
Sandoval-Chacon M, Thompson JH, Zhang X-J, et al. Antiinflammatory actions of cat's claw: the role of NF-kB. Alimentary Pharmacology and Therapeutics, 1998;12:1279-1289.
The information provided by Jack Challem is strictly educational and not intended as medical
advice. For diagnosis and treatment, consult your physician.